Your browser doesn't support javascript.
loading
Effect of a Diagnostic Strategy Using an Elevated and Age-Adjusted D-Dimer Threshold on Thromboembolic Events in Emergency Department Patients With Suspected Pulmonary Embolism: A Randomized Clinical Trial.
Freund, Yonathan; Chauvin, Anthony; Jimenez, Sonia; Philippon, Anne-Laure; Curac, Sonja; Fémy, Florent; Gorlicki, Judith; Chouihed, Tahar; Goulet, Hélène; Montassier, Emmanuel; Dumont, Margaux; Lozano Polo, Laura; Le Borgne, Pierrick; Khellaf, Mehdi; Bouzid, Donia; Raynal, Pierre-Alexis; Abdessaied, Nizar; Laribi, Saïd; Guenezan, Jeremy; Ganansia, Olivier; Bloom, Ben; Miró, Oscar; Cachanado, Marine; Simon, Tabassome.
Afiliação
  • Freund Y; Sorbonne Université, Improving Emergency Care FHU, Paris, France.
  • Chauvin A; Emergency Department, Hôpital Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Jimenez S; Emergency Department, Hôpital Lariboisière, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Philippon AL; Emergency Department, Hospital Clínic, IDIBAPS, Barcelona, University of Barcelona, Catalonia, Spain.
  • Curac S; Sorbonne Université, Improving Emergency Care FHU, Paris, France.
  • Fémy F; Emergency Department, Hôpital Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Gorlicki J; Emergency Department, Hôpital Beaujon, Assistance Publique-Hôpitaux de Paris, Clichy, France.
  • Chouihed T; Emergency Department, Hôpital Européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris, Paris University, Paris, France.
  • Goulet H; Toxicology and Chemical Risks Department, French Armed Forces Biomedical Institute, Bretigny-Sur-Orges, France.
  • Montassier E; Emergency Department, Hôpital Avicenne, Assistance Publique-Hôpitaux de Paris, INSERM U942-MASCOT, Bobigny, France.
  • Dumont M; Emergency Department, University Hospital of Nancy, Université de Lorraine, UMR_S 1116, Nancy, France.
  • Lozano Polo L; Emergency Department, Hôpital Tenon, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Le Borgne P; Emergency Department, CHU Nantes, Nantes, France.
  • Khellaf M; Emergency Department, Hôpital Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Bouzid D; Emergency Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Universitat Autònoma de Barcelona, Catalonia, Spain.
  • Raynal PA; Emergency Department, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
  • Abdessaied N; Emergency Department, CHU Henri Mondor, INSERM U955, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Laribi S; Université de Paris, INSERM, IAME, F-75006 Paris, France.
  • Guenezan J; Emergency Department, Bichat-Claude Bernard University Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Ganansia O; Emergency Department, Hôpital St-Antoine, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Bloom B; Emergency Department, Centre Hospitalier de St Denis, St Denis, France.
  • Miró O; Tours University, Emergency Medicine Department, Tours University Hospital, Tours, France.
  • Cachanado M; Emergency Department, University Hospital of Poitiers, Poitiers, France.
  • Simon T; Emergency Department, Groupe Hospitalier Paris-St Joseph, Paris, France.
JAMA ; 326(21): 2141-2149, 2021 12 07.
Article em En | MEDLINE | ID: mdl-34874418
ABSTRACT
Importance Uncontrolled studies suggest that pulmonary embolism (PE) can be safely ruled out using the YEARS rule, a diagnostic strategy that uses varying D-dimer thresholds.

Objective:

To prospectively validate the safety of a strategy that combines the YEARS rule with the pulmonary embolism rule-out criteria (PERC) rule and an age-adjusted D-dimer threshold. Design, Settings, and

Participants:

A cluster-randomized, crossover, noninferiority trial in 18 emergency departments (EDs) in France and Spain. Patients (N = 1414) who had a low clinical risk of PE not excluded by the PERC rule or a subjective clinical intermediate risk of PE were included from October 2019 to June 2020, and followed up until October 2020.

Interventions:

Each center was randomized for the sequence of intervention periods. In the intervention period (726 patients), PE was excluded without chest imaging in patients with no YEARS criteria and a D-dimer level less than 1000 ng/mL and in patients with 1 or more YEARS criteria and a D-dimer level less than the age-adjusted threshold (500 ng/mL if age <50 years or age in years × 10 in patients ≥50 years). In the control period (688 patients), PE was excluded without chest imaging if the D-dimer level was less than the age-adjusted threshold. Main Outcomes and

Measures:

The primary end point was venous thromboembolism (VTE) at 3 months. The noninferiority margin was set at 1.35%. There were 8 secondary end points, including chest imaging, ED length of stay, hospital admission, nonindicated anticoagulation treatment, all-cause death, and all-cause readmission at 3 months.

Results:

Of the 1414 included patients (mean age, 55 years; 58% female), 1217 (86%) were analyzed in the per-protocol analysis. PE was diagnosed in the ED in 100 patients (7.1%). At 3 months, VTE was diagnosed in 1 patient in the intervention group (0.15% [95% CI, 0.0% to 0.86%]) vs 5 patients in the control group (0.80% [95% CI, 0.26% to 1.86%]) (adjusted difference, -0.64% [1-sided 97.5% CI, -∞ to 0.21%], within the noninferiority margin). Of the 6 analyzed secondary end points, only 2 showed a statistically significant difference in the intervention group compared with the control group chest imaging (30.4% vs 40.0%; adjusted difference, -8.7% [95% CI, -13.8% to -3.5%]) and ED median length of stay (6 hours [IQR, 4 to 8 hours] vs 6 hours [IQR, 5 to 9 hours]; adjusted difference, -1.6 hours [95% CI, -2.3 to -0.9]). Conclusions and Relevance Among ED patients with suspected PE, the use of the YEARS rule combined with the age-adjusted D-dimer threshold in PERC-positive patients, compared with a conventional diagnostic strategy, did not result in an inferior rate of thromboembolic events. Trial Registration ClinicalTrials.gov Identifier NCT04032769.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Embolia Pulmonar / Produtos de Degradação da Fibrina e do Fibrinogênio / Tromboembolia Venosa Tipo de estudo: Clinical_trials / Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Embolia Pulmonar / Produtos de Degradação da Fibrina e do Fibrinogênio / Tromboembolia Venosa Tipo de estudo: Clinical_trials / Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Ano de publicação: 2021 Tipo de documento: Article